Veterinary Medicines

AMPICILLIN LA

Authorised
  • AMPICILLIN, ANHYDROUS
Download as PDF

Product identification

Medicine name:
AMPICILLIN LA
Active substance:
  • AMPICILLIN, ANHYDROUS
Target species:
  • Cattle
  • Dog
  • Sheep
  • Cat
  • Pig
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • AMPICILLIN, ANHYDROUS
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        4
        day
    • Dog
    • Sheep
      • Meat and offal
        28
        day
    • Cat
    • Pig
      • Meat and offal
        28
        day
  • Intramuscular use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        4
        day
    • Dog
    • Sheep
      • Meat and offal
        28
        day
    • Cat
    • Pig
      • Meat and offal
        28
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01C
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • 13144
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."